BJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

British Journal of Radiology (2008) 81, 327-332
© 2008 British Institute of Radiology
doi: 10.1259/bjr/75868623

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O'DONNELL, H E
Right arrow Articles by PLOWMAN, P N
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O'DONNELL, H E
Right arrow Articles by PLOWMAN, P N

Full paper

Re-defining rectal volume and DVH for analysis of rectal morbidity risk after radiotherapy for early prostate cancer

H E O'DONNELL, BA, MRCP, FRCR1, K FINNEGAN1, H ELIADES2, S OLIVEROS, MRCP, FRCR1 and P N PLOWMAN, MA, MD, FRCP, FRCR1,2

1 Department of Radiotherapy, St Bartholomew's Hospital, West Smithfield, London, 2 Department of Radiotherapy, Cromwell Hospital London, London, UK

Correspondence: Dr Nick Plowman, Senior Consultant in Clinical Oncology and Radiotherapy, Department of Radiotherapy, St Bartholomew's Hospital, West Smithfield, London EC1A 7BE, UK. E-mail: nick.plowman{at}bartsandthelondon.nhs.uk

Improved prostate cancer cure rates have been attributed to higher radiotherapy dose prescriptions delivered more safely by modern conformal/intensity-modulated radiotherapy (IMRT) methods. As the dose becomes more concentrated conformally on the prostate, the volume of the rectum "at risk" for damage becomes smaller and more focal on the anterior rectal wall between the upper and lower axial limits of the planning target volume (PTV). The rectal dose–volume histogram (DVH) traditionally studies the whole volume of the rectum, and such definition for "avoidance" planning presupposes that rectal tolerance depends on "whole organ" radiation tolerance (as might, for example, lung or kidney). However, rectal morbidity with modern prostate radiotherapy is determined by anterior rectal wall tolerance between the superior and inferior limits of the PTV; this, we argue, is not dependent on whole organ tolerance. Recent published studies attempting to improve rectal DVH definition have studied the rectal wall only and concluded that rectal wall DVH is more relevant than whole rectum. In this manuscript, it is first demonstrated that a large and more relevant difference exists when comparing whole rectal DVH to "PTV limits" rectal DVH. Secondly, when considering "PTV limits" rectal DVH, the wall vs whole perimeter comparison differs little. Furthermore, by adopting a "PTV limits" DVH, the inferior right quartile of the DVH accurately reflects the dose distribution to the most vulnerable section of the anterior rectal wall. With improving IMRT technologies, scrutiny of this part of the rectal DVH will most accurately predict rectal sparing — reflected in this manuscript by the less precipitous decline of the TomoTherapy® DVH vs the three-dimensional conformal DVH towards the maximum dose point received by the rectum.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
BJR DMFR IMAGING  ALL BIR JOURNALS 
Copyright © 2008 by the British Institute of Radiology.